Dunja Sobot is currently holding a position of Senior Manager in Technical R&D
Global Drug Product, GSK Vaccines in Belgium. She is leading a team of scientists
with a main focus on development of new vaccine formulations and implementation of innovative technologies for vaccine delivery, especially in the field of adjuvant systems. Dunja holds a PhD in Pharmaceutical Technology (investigation of interactions between blood components and nanoparticles for delivery of anticancer compounds) from the University of Paris Sud XI (under the supervision of Prof. Patrick Couvreur and Dr. Simona Mura). Furthermore, she holds a MSc. in Pharmacokinetics from the University of Aix Marseille II and a MPharm degree from the University of Belgrade.